Patients should also seek medical advice if muscle symptoms are accompanied by systemic features such as fever, unexplained weight loss beyond what is expected from GLP-1 therapy, rash, joint swelling, or other concerning signs that might suggest inflammatory or autoimmune conditions
B., Constantin-Teodosiu, D
Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice
Timing and Strain Selection Matter for Best Results The type of probiotic strain you choose influences effectiveness alongside GLP-1 therapy
Mean change in body weight from baseline to Week 52 was a secondary endpoint.* Statistically significant vs Januvia 100 mg PIONEER 3 study design 1,4 In a double-blind, double-dummy trial with a primary endpoint of mean change in A1C from baseline to 26 weeks, 1864 adult patients with type 2 diabetes on metformin alone or metformin with a sulfonylurea were randomized to RYBELSUS 3 mg (n=466), RYBELSUS 7 mg (n=465), RYBELSUS 14 mg (n=465), or Januvia 100 mg (n=467), all once daily
One treatment option that has garnered attention in recent years is Ozempic ( Semaglutide GLP-1 )